"Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype.
Clinical trial NCT05914584 · UNKNOWN
Trial details
- NCT number
- NCT05914584
- Sponsor
- Nantes University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2025-08-31
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.